| Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score J Hasford, M Baccarani, V Hoffmann, J Guilhot, S Saussele, G Rosti, ... Blood, The Journal of the American Society of Hematology 118 (3), 686-692, 2011 | 650 | 2011 |
| The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries VS Hoffmann, M Baccarani, J Hasford, D Lindörfer, S Burgstaller, D Sertic, ... Leukemia 29 (6), 1336-1343, 2015 | 287 | 2015 |
| Treatment and outcome of 2904 CML patients from the EUTOS population-based registry VS Hoffmann, M Baccarani, J Hasford, F Castagnetti, F Di Raimondo, ... Leukemia 31 (3), 593-601, 2017 | 120 | 2017 |
| The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib VS Hoffmann, M Baccarani, D Lindörfer, F Castagnetti, A Turkina, ... Leukemia 27 (10), 2016-2022, 2013 | 94 | 2013 |
| A comprehensive assessment tool for patient registry software systems: the CIPROS checklist D Lindörfer, U Mansmann Methods of Information in Medicine 54 (05), 447-454, 2015 | 22 | 2015 |
| The EUTOS CML score aims to support clinical decision-making V Hoffmann, M Baccarani, J Hasford, J Guilhot, S Saussele, G Rosti, ... Blood, The Journal of the American Society of Hematology 119 (12), 2966-2967, 2012 | 17 | 2012 |
| Enhancing requirements engineering for patient registry software systems with evidence-based components D Lindoerfer, U Mansmann Journal of biomedical informatics 71, 147-153, 2017 | 15 | 2017 |
| Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models D Vangala, S Ladigan, ST Liffers, S Noseir, A Maghnouj, TM Götze, ... Genome medicine 13 (1), 1-25, 2021 | 11 | 2021 |
| Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective … S Hoffmann, A Crispin, D Lindoerfer, G Sroczynski, U Siebert, ... BMC gastroenterology 20 (1), 1-9, 2020 | 11 | 2020 |
| Incidence of CML in Europe—a Comparison of 19 European Countries with US SEER Data VS Hoffmann, D Lindoerfer, J Thaler, L Boris, F Melanthiou, J Mayer, ... Blood 124 (21), 3145, 2014 | 6 | 2014 |
| Survival and prognosis in patients with first-line imatinib treatment under particular consideration of death due to chronic myeloid leukemia M Pfirrmann, S Saussele, M Baccarani, J Guilhot, F Cervantes, ... Blood 124 (21), 153, 2014 | 6 | 2014 |
| Baseline characteristics of CML patients accross Europe-comparing real-world patients with patient collectives included in clinical trials M Baccarani, VS Hoffmann, G Rosti, F Castagnetti, S Saussele, J Guilhot, ... Blood 124 (21), 3160, 2014 | 5 | 2014 |
| Data for the elaboration of the CIPROS checklist with items for a patient registry software system: Examples and explanations D Lindoerfer, U Mansmann Data in brief 14, 494-497, 2017 | 4 | 2017 |
| IT infrastructure of an oncological trial where xenografts inform individual second line treatment decision D Lindoerfer, U Mansmann Stud Health Technol Inform 235, 226-230, 2017 | 4 | 2017 |
| CIPROS-A checklist with items for a patient registry software system. D Lindoerfer, U Mansmann MIE, 161-165, 2014 | 4 | 2014 |
| The EUTOS Population-Based Registry: Evaluation of baseline characteristics and first treatment choices of 2983 newly diagnosed chronic myeloid leukemia (CML) patients from 20 … D Lindörfer, VS Hoffmann, G Rosti, F Castagnetti, S Saussele, J Guilhot, ... Haematologica, 2014 | 4 | 2014 |
| EUTOS score is also valid in CML patients not involved in clinical studies VS Hoffmann, J Mayer, AG Turkina, A Hellmann, K Indrak, JL Steegmann, ... Blood 120 (21), 3759, 2012 | 4 | 2012 |
| THE EUTOS HIGH RISK POPULATION DIFFERS SUBSTANTIALLY FROM THE EURO HIGH RISK GROUP; THE EUTOS SCORE PREDICTS MOLECULAR RESPONSE IN CHRONIC PHASE CML PATIENTS: RESULTS OF THE … S Saussele, M Lauseker, V Hoffmann, D Lindörfer, B Hanfstein, U Proetel, ... Haematologica 97, 454-454, 2012 | 4 | 2012 |
| Der EUTOS-Score: Vorhersage von kompletter zytogenetischer Remission und progressionsfreiem Uberle-ben bei CML-Patienten unter Imatinibtherapie V Hoffmann, J Hasford, S Saussele, D Lindörfer, M Pfirrmann, ... Leukämie Rundbrief 16, 11-2, 2011 | 3 | 2011 |
| A proposal of Checklist Items for evaluating a patient registry software system. D Lindörfer, U Mansmann | 2 | 2014 |
